PRELIMINARY-RESULTS OF A DOSE-FINDING STUDY OF TOMUDEX WITH CISPLATINAND EPIRUBICIN AS FIRST-LINE THERAPY FOR METASTATIC OR UNRESECTABLE GASTRIC AND ESOPHAGEAL ADENOCARCINOMA
Mm. Eatock et al., PRELIMINARY-RESULTS OF A DOSE-FINDING STUDY OF TOMUDEX WITH CISPLATINAND EPIRUBICIN AS FIRST-LINE THERAPY FOR METASTATIC OR UNRESECTABLE GASTRIC AND ESOPHAGEAL ADENOCARCINOMA, Annals of oncology, 9, 1998, pp. 235-235